adverse events

In this episode, Meredith Clement, MD, and Whitney C. Irie, MSW, PhD, discuss key considerations for pre-exposure prophylaxis (PrEP) uptake in cisgender women, including: 

• How to incorporate conversations on PrEP during a short clinic visit 
• Helpful resources about PrEP to share with patients
• Leveraging clinic staff to improve PrEP uptake and persistence 
• Available data on on-demand PrEP
• Approach to discussing PrEP contraindications and adverse events with patients
• Considerations for PrEP in pregnant persons or those wanting to conceive 
• The importance of inclusiveness in PrEP marketing 
• Key barriers limiting PrEP uptake in cisgender women (eg, stigma, risk perception)
• Interventions to improve PrEP uptake

Faculty

Meredith Clement, MD
Associate Professor 
Infectious Diseases 
Louisiana State University 
Health Sciences Center
New Orleans, Louisiana 

Whitney C. Irie, MSW, PhD
Assistant Professor
Department of Social Work
Boston College
Brighton, Massachusetts 

Link to full program: 
https://bit.ly/3PZGYdR

What about you only have 10 minutes of your time to get to know a Second Victim support program? Today we have a different format of the Podcast. Leaders from 5 Second Victim interventions kindly share with us their programs in a clear and short manner. Also, we will listen to some of the barriers and facilitators that they found in the program implementation process.

In this podcast we learn about the MISE Program, from Spain. The MISE Program is an online program, with a preventive nature, focused on supporting healthcare workers on a national level by providing them knowledge about patience safety and the Second Victim phenomenon.

If you liked this content, please visit our website https://cost-ernst.eu — and to know more about the Training School, visit https://cost-ernst.eu/news/training-school-2023-wiesbaden/

Thank you very much for listening to The Second Victims Podcast!

See you soon and stay tuned!

What about you only have 10 minutes of your time to get to know a Second Victim support program? Today we have a different format of the Podcast. Leaders from 5 Second Victim interventions kindly share with us their programs in a clear and short manner. Also, we will listen to some of the barriers and facilitators that they found in the program implementation process.

In this podcast we talk with Dr. Elisabeth Krommer about the KoHi Program, from Austria. The KoHi Program provides psychological first aid for healthcare workers after stressful events.

If you liked this content, please visit our website https://cost-ernst.eu — and to know more about the Training School, visit https://cost-ernst.eu/news/training-school-2023-wiesbaden/

Thank you very much for listening to The Second Victims Podcast!

See you soon and stay tuned!

What about you only have 10 minutes of your time to get to know a Second Victim support program? Today we have a different format of the Podcast. Leaders from 5 Second Victim interventions kindly share with us their programs in a clear and short manner. Also, we will listen to some of the barriers and facilitators that they found in the program implementation process.

In this podcast we talk with Rev. Matt Norvell, the Co-developer of RISE Program (Resilience In Stressful Events), from the USA. The RISE Program provides emotional first aid to hospital employees who have experienced stressful, patient-related events.

If you liked this content, please visit our website https://cost-ernst.eu — and to know more about the Training School, visit https://cost-ernst.eu/news/training-school-2023-wiesbaden/

Thank you very much for listening to The Second Victims Podcast!

See you soon and stay tuned!

What about you only have 10 minutes of your time to get to know a Second Victim support program? Today we have a different format of the Podcast. Leaders from 5 Second Victim interventions kindly share with us their programs in a clear and short manner. Also, we will listen to some of the barriers and facilitators that they found in the program implementation process.

In this podcast we talk with Dr. Giancarlo Colombo about the Einstein Hospital Program, from Brazil. The Albert Einstein Hospital was the first institution outside the USA to be certified by the Joint Commission International

If you liked this content, please visit our website https://cost-ernst.eu — and to know more about the Training School, visit https://cost-ernst.eu/news/training-school-2023-wiesbaden/

Thank you very much for listening to The Second Victims Podcast!

See you soon and stay tuned!

In this podcast episode, Samuel Klempner, MD, and Gregory Botta, MD, PhD, provide expert commentary on the rationale and development of novel agents under investigation for targeting claudin 18.2 in gastric and gastroesophageal cancers, with topics including:

• Expression patterns and function of the claudin family of proteins in normal gastric tissues
• Biologic rationale for utility of claudin 18.2 as an actionable therapeutic target in oncology
• Prognostic implications of claudin 18.2 overexpression in gastric and gastroesophageal cancers
• Laboratory methodology involved in claudin 18.2 scoring as a potential predictive biomarker for patient selection
• Future directions for clinical development of agents targeting claudin 18.2, including monoclonal antibodies, bispecific antibodies, antibody‒drug conjugates, and CAR T-cell constructs

Presenters:

Samuel Klempner, MD
Associate Professor
Department of Medicine
Division of Hematology-Oncology
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

Gregory Botta, MD, PhD
Clinical Professor of Medicine
Department of Medicine
Division of Hematology & Oncology
University of California San Diego
La Jolla, California

Content for this program was supported by educational grants from Astellas and Bristol Myers Squibb.

Link to the full program, including a CME-certified text module, downloadable slideset, and ClinicalThought (coming soon!):
bit.ly/3lQxPrq

Rett syndrome is a rare but severe neurodevelopmental disorder, and current treatment approaches primarily focus on symptom management and supportive care. However, recent clinical developments are providing hope for a changing treatment landscape. In this podcast episode, experts in Rett syndrome David N. Lieberman, MD, PhD, and Jeffrey Neul, MD, PhD, discuss trofinetide and blarcamesine, 2 agents in late-stage clinical trials as treatment options for Rett syndrome. Throughout their conversation, Drs Lieberman and Neul review the pivotal LAVENDER, DAFFODIL, AVATAR, and EXCELLENCE trials, including information on the safety and efficacy profiles of trofinetide and blarcamesine. The experts end their discussion with a conversation about the potential roles of ketamine and gene therapy in the management of Rett syndrome.      

Presenters:

David N. Lieberman, MD, PhD
Instructor
Department of Neurology
Harvard Medical School
Attending Physician
Child Neurology
Boston Children’s Hospital
Boston, Massachusetts

Jeffrey Neul, MD, PhD
Director
Pediatrics
Vanderbilt University Medical Center
Nashville, Tennessee

This activity is supported by educational funding provided by Acadia Pharmaceuticals Inc.

To claim CME/CE credit for this podcast, complete the posttest here:
 bit.ly/3JR4qq5.

For additional activities in this program, visit
 bit.ly/3JR4qq5

In this podcast episode from a live CCO Cancer Conversations webinar, Mark Pegram, MD, and Sara Tolaney, MD, MPH, provide expert perspectives on optimal treatment strategies for patients with triple-negative breast cancer (TNBC), with topics including:

• Current data and strategies for using PD-1/PD-L1 inhibitors in early-stage TNBC 
• Clinical implications of PD-L1 status on therapeutic planning for patients with metastatic TNBC 
• Current data and treatment strategies and the future of antibody–drug conjugates in the management of relapsed/refractory advanced TNBC 
• Treatment implications of the presence of BRCA1/2 mutations and homologous recombination deficiency genes in advanced TNBC
• Role of PARP inhibitors in the treatment of TNBC

Presenters: 

Mark Pegram, MD
Professor 
Medical Oncology
Stanford University
Palo Alto, California

Sara Tolaney, MD, MPH
Associate Professor of Medicine
Division of Breast Oncology
Harvard Medical School
Chief, Division of Breast Oncology
Breast Oncology Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Content based on an online CME/CE/CPE program supported by educational grants from Gilead Sciences, Inc.

Link to full program:
http://bit.ly/3iQzDz5

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses PrEP uptake for cisgender women. His discussion includes: 

• Prevalence of PrEP use in cisgender women in the United States
• Barriers to PrEP uptake in cisgender women
• Implementation of PrEP within family planning clinics in Atlanta
• PrEP in pregnancy and breastfeeding

Presenter: 

Timothy J. Wilkin, MD, MPH
Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York

Link to full program: 
http://bit.ly/3UFUl2b

Follow along with the slides at:
http://bit.ly/3TDOPM8

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for adolescents. His discussion includes: 

• How PrEP is underused in adolescents and young adults
• Healthcare professional barriers to provision of PrEP for adolescents
• A systematic review and meta-analysis of adherence to PrEP in adolescents and young adults
• Barriers to adherence in adolescents and young adults
• Interventions to support PrEP adherence in adolescents

Presenter: 

Timothy J. Wilkin, MD, MPH
Professor of Medicine
Division of Infectious Diseases
Weill Medical College of Cornell University
New York, New York

Link to full program: 
https://bit.ly/3VIsDTg

Follow along with the slides at:
https://bit.ly/3EcaYg0
 

In this episode, Lilian Abbo, MD, FIDSA; Julie Ann Justo, PharmD, MS; and David van Duin, MD, PhD, FIDSA, FAST, discuss key concepts about extraintestinal pathogenic Escherichia coli, including:

• Diverse strains and virulence factors associated with invasive disease
• Antimicrobial resistance profiles seen in clinical practice
• Various disease manifestations
• Prevalence and burden of invasive infections
• Populations at risk
• Risk factors for multidrug-resistant strains
• Emerging vaccine technologies
• Active clinical trials 
• Benefits of vaccines and the challenges associated with development
• Importance of antimicrobial stewardship and potential role of vaccines to reduce antimicrobial resistance

Program Director: 
Lilian Abbo, MD, FIDSA
Associate Chief Medical Officer in Infectious Diseases
Jackson Health System
Professor of Infectious Diseases
Department of Medicine & Miami Transplant Institute
University of Miami Miller School of Medicine
Miami, Florida

Faculty:
Julie Ann Justo, PharmD, MS
Clinical Associate Professor
Department of Clinical Pharmacy and Outcomes Sciences
University of South Carolina College of Pharmacy
Infectious Diseases Clinical Pharmacy Specialist
Department of Pharmacy
Prisma Health Richland Hospital
Columbia, South Carolina

David Van Duin, MD, PhD, FIDSA, FAST
Professor of Medicine 
Director, Immunocompromised Host Infectious Diseases Program
Division of Infectious Diseases
University of North Carolina
Chapel Hill, North Carolina

Content based on a CME program supported by an educational grant from Janssen Therapeutics.

Follow along with a downloadable slideset at:
https://bit.ly/3eG29Bn

Link to full program:
https://bit.ly/3eFHfCl

Some of the HUGE topics covered in this episode with Karen Kingston:

• Cov'd-19 injections contain NEUROWEAPONS embedded in Lipid Nanoparticles (LNP)
• Neurological weapons were hidden through Emergency Use Authorization cover-up
• Shocking patents confirm it's all true (patent numbers shown)
• Transhumanism assault on humanity now under way, people becoming LESS human
• LNPs can be activated via 5G frequencies to achieve physiological changes
• Cov'd "v-accines" appear to be exotic tech INSTALLED in human hosts
• CCP-linked AI company named "national security threat" in USA
• 5G infrastructure to be exploited by AI embedded systems for surveillance
• Post-Vax "biostructures" are self-assembling biosynthetic weapons

Rumble - https://rumble.com/v1n9zh4-biotech-analyst-karen-kingston-unveils-the-covid-vaccine-5g-link-biosynthet.html
Podcast - https://jsk.transistor.fm
Patreon (Donate) - https://patreon.com/ownershipeconomy

Western Australia, one of the most radical states Downunder, has passed a bill that grants 'officers' authorization to strip people from their homes and vaccinate them against their will. The “Emergency Management Amendment” legislation passed last year. The amendment includes “Powers of officers in relation to persons exposed to SARS-CoV-2 virus.”

So, why did the CDC want to hide these records from the public?

Victory for Lawyer, Aaron Siri, who has finally obtained the reports that the CDC didn’t want you to see. 7.7% of 10 million had to seek medical care post inject. A staggering 25% missed work and had some serious event affecting their normal lives. V-safe records only contain information of 10 million people. Compared to the billions of people have taken these experimental gene therapies.

All of this and more on today's episode of The Jonathan Kogan Show!

Support the podcast via Patreon or "Buy me a Coffee"!

Rumble - https://rumble.com/user/ownershipeconomy
Podcast - https://jsk.transistor.fm/
Patreon - https://www.patreon.com/ownershipeconomy

Safe and Effective: A Second Opinion shines a light on Covid-19 vaccine injuries and bereavements, but also takes an encompassing look at the systemic failings that appear to have enabled them.

We look at leading analysis of pharmaceutical trials, the role of the MHRA in regulating these products, the role of the SAGE behavioral scientists in influencing policy and the role of the media and Big Tech companies in suppressing free and open debate on the subject.

All of this and more breaking news on The Jonathan Kogan Show!

*I messed up the recording between 00:29:00 and 00:37:00 so please skip (or watch it all on Rumble!)**

Rumble - https://rumble.com/v1m7npy-safe-and-effective-a-second-opinion-91.html
Podcast - https://jsk.transistor.fm

Exclusive testimony of Army Whistleblower LtCol Theresa Long MD (flight surgeon). Her testimony shows how the DOD, FDA and many other organizations are violating federal code and how the jabs are causing vaccine injuries to fighter pilots as well as their medical records are being falsified to cover up jab injuries. Injuries from brain tumors, cancer, and deadly heart conditions she shows how the jabs are injuring and grounding many young military pilots. Find out the dangers they are facing.

LtCol Theresa Long MD gave her "Whistleblower" testimony to the Alaska Medical Freedom Symposium in Palmer, Alaska. Hundreds were in in attendance with many more watching live online across the state and throughout the U.S and Canada.

Army LtCol Theresa Long MD give her heartfelt testimony just days after the passing of her Father.

Help spread her word as people need to hear the truth. Please like and share. Thank you!

Rumble: https://rumble.com/user/ownershipeconomy
Podcast: https://jsk.transistor.fm

A federal court in Texas is giving the Centers for Disease Control and Prevention (CDC) until Friday to release the first batch of data on adverse events following COVID-19 vaccination collected by the agency via its V-safe app. According to ICAN, the court order requires the CDC to release the first batch of 19 months’ worth of data collected from millions of participants who reported adverse events related to COVID-19 vaccination via the V-safe app between Dec. 14, 2020, and July 31, 2022.

In all, the CDC will be required to release more than 137 million health V-safe entries.

Other news covered:

• Pentagon opens sweeping review of clandestine psychological operations
• Dr. Aseem Malhotra (mainstream UK cardiologist) publishes new peer reviewed evidence calls for all Covid-19 vaccines to be withdrawn
• Bill Gates says political polarization 'may bring it all to an end' and could even lead to a civil war
• Another One: Teen Athlete Dies Suddenly While at Golf Practice - Unknown Cause of Death
• Less than 2% of eligible people have gotten updated Covid booster shots, 3 weeks into the rollout
• Bill Gates brags about ordering Trump not to investigate covid vaccine dangers

Announcement!

• Also, if you want to donate to my hurricane coverage in Florida this week check out the GoFundMe here: https://gofund.me/83107967 (check the description in the GoFundMe to see videos from my 2017 coverage when Hurricane Irma destroyed Miami!)
• Buy me a coffee!
• Watch on Rumble: https://rumble.com/v1lnter-cdc-has-4-days-to-release-data-on-covid-vaccine-injuries-89.html

In this episode we meet Dr Hasib Sidiqi from Fiona Stanley Hospital in Perth, Western Australia. We will be talking about clinical trials and why they’re so important as an option of therapy for people living with myeloma. We will delve into the structure and phases of clinical trials, eligibility for trials and some of the pro’s and cons of being involved in a clinical trial. We will also find out about some of the trials happening now in Australia for the myeloma community and how to know what trials are available to you. We will also be speaking to Karen Wilde about her personal experience as part of the … trial and also being a regional patient. 

In this episode, Amanda Zimmerman, PA-C, sheds light on the opioid crisis in the United States. She brings attention to the fact that prescription pain medications can be a gateway to substance misuse and opioid use disorder not just for the individuals who were prescribed the medication, but also for those around them—emphasizing the importance of counseling patients on safe opioid practices. Counseling points include when patients should contact their providers, how to store pain medication, and how to dispose of pain medications. Listen as Ms Zimmerman conducts a patient visit to demonstrate how to effectively communicate these points in clinical practice.

Presenters: 
Amanda Zimmerman, PA-C
Physician Assistant
West Forsyth Pain Management
Winston-Salem, North Carolina

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see
https://bit.ly/3mgrfb9 
for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Provided by Clinical Care Options, LLC, and in partnership with the American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE.

Link to full program:
https://bit.ly/3mcDHsi

 In lieu of the Pfizer documents slowly oozing out that reveal numerous unreported adverse events as a result of their Covid vaccine, including higher rates of Myocarditis, Carl explains why Americans must be informed of the Nuremberg code so that America never looks like Communist China, particularly Shanghai.

See omnystudio.com/listener for privacy information.